Report Description Datamonitor's Quintiles Transnational Corp. - SWOT Company Profile is the essential source for top-level company data and information. The report examines the company's key business structure ...

Report Description Datamonitor's Rigel Pharmaceuticals, Inc. - SWOT Company Profile is the essential source for top-level company data and information. The report examines the company's key business structure ...

Report Description Datamonitor's PDL Biopharma - SWOT Company Profile is the essential source for top-level company data and information. The report examines the company's key business structure and ...

Report Description Datamonitor's CV Therapeutics, Inc. - SWOT Company Profile is the essential source for top-level company data and information. The report examines the company's key business structure ...

Report Description Datamonitor's Idenix Pharmaceuticals, Inc. - SWOT Company Profile is the essential source for top-level company data and information. The report examines the company's key business structure ...

Report Description Datamonitor's Acorda Therapeutics - SWOT Company Profile is the essential source for top-level company data and information. The report examines the company's key business structure and ...

Report Description Datamonitor's Progenics Pharmaceuticals, Inc. - SWOT Company Profile is the essential source for top-level company data and information. The report examines the company's key business structure ...

Report Description Datamonitor's Sunesis Pharmaceuticals, Inc - SWOT Company Profile is the essential source for top-level company data and information. The report examines the company's key business structure ...

Report Description Datamonitor's Myriad Genetics, Inc. - SWOT Company Profile is the essential source for top-level company data and information. The report examines the company's key business structure ...

Report Description Datamonitor's Neose Technologies, Inc. - SWOT Company Profile is the essential source for top-level company data and information. The report examines the company's key business structure ...

Report Description Datamonitor's Third Wave Technologies, Inc. - SWOT Company Profile is the essential source for top-level company data and information. The report examines the company's key business ...

The company recorded revenues of DKK41,831 million (approximately $7,696.5 million) during the fiscal year ended December 2007, an increase of 8% over 2006. The operating profit of the company ...

The company recorded revenues of $2,038.7 million during the fiscal year ended December 2007, an increase of 13.4% over 2006. The operating profit of the company was $459.6 million ...

Amgen is a biotechnology company engaged in discovering, developing, manufacturing, and marketing of human therapeutics. The company primarily operates in the US. It is headquartered in Thousand Oaks, California ...

CollaGenex Pharmaceuticals (CollaGenex) is a specialty pharmaceutical company focused on providing medical therapies for dermatological diseases. The company primarily operates in the US. The company is headquartered in Newtown, ...

Cytogen is a specialty pharmaceutical company focused on building, developing, and commercializing a portfolio of oncology products for the treatment and care of cancer patients. The company currently markets ...

BioMarin Pharmaceutical (BioMarin) is engaged in development and commercialization of biopharmaceuticals. The company select product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood ...

Progenics Pharmaceuticals (Progenics) is a biopharmaceutical company engaged in the development and commercialization of innovative therapeutic products to meet the medical needs of patients with debilitating conditions and life-threatening ...

The company recorded revenues of E131.6 million during the fiscal year ended December 2006, an increase of 302% over 2005. The operating loss of the company was E97.9 million ...

The company recorded revenues of £17.7 million during the fiscal year ended March 2006, a decrease of 6% over 2005. The operating loss of the company was £9.5 million ...